MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window

Neurology

Volumn 65, Issue 4, 2005, Pages 612-615

  Mitsias, Panayiotis D ^a   Lu, M ^b   Silver, B ^a   Morris, D ^b   Ewing, J R ^a,b   Daley, S ^a   Lewandowski, C ^b   Katramados, A ^a   Papamitsakis, N I ^c   Ebadian, H B ^a   Zhao, Q ^a   Soltanian Zadeh, H ^b   Hearshen, D ^b   Patel, S C ^b   Chopp, M ^a,d  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SCIENCES CENTER   (United States)

^c NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^d OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; TROPONIN;

ADULT; AGED; ALGORITHM; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN HERNIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RATING SCALE; THROMBOCYTOPENIA;

EID: 23844543072     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000172862.33641.92     Document Type: Article

References (10)

1. Zhang ZG, Zhang L, Tsang L, et al. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res 2001;912:181-194.
2. Choudhri TF, Hoh BL, Zerwes HG, et al. Reduced microvascular thrombosis and improved outcome in acute marine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998;102:1301-1310.
3. Montalescot G, Barragan P, Wittenberg O, et al. Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term follow-up. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-1903.
4. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601-609.
5. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;41:581-589.
6. Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28-37.
7. Mitsias PD, Jacobs MA, Hammoud R, et al. Multiparametric MRI ISO-DATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques. Stroke 2002;33:2839-44.
8. Haley EC Jr., Lewandowski C, Tilley BC, et al. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med 1997;30:676-682.
9. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426.
10. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-1556.